Breast Neoplasms
📧 Sign up to get email alerts when something new happens for Breast Neoplasms.
Sign up freeTop drugs studied for this disease
-
EMA withdrawal · 2016-09-29EMA Application withdrawn: Docetaxel SUN — Sun Pharmaceutical Industries Europe B.V.
The EMA withdrew the application for Docetaxel SUN by Sun Pharmaceutical Industries Europe B.V. for multiple cancer indications.
-
CLINICAL_TRIALS trial_result · 2016-09-20Clinical Trial Update: The Assessment of Molecular Breast Imaging (MBI) in Distinguishing Benign From Malignant Breast Disease [NA]
A completed trial evaluating Molecular Breast Imaging (MBI) for distinguishing benign from malignant breast disease, with results posted in …
-
CLINICAL_TRIALS research · 2016-09-07Clinical Trial Update: The Breast Surgery EnLight and LightPath Imaging System Study [Phase 1, Phase 2]
Update on a Phase 1/Phase 2 study of the Breast Surgery EnLight and LightPath Imaging System for breast neoplasms; current status is not pro…
-
CLINICAL_TRIALS trial_result · 2016-08-16Clinical Trial Update: Single Versus Multiple Injection Ultrasound Guided Paravertebral Blocks [NA]
A completed clinical trial comparing single versus multiple ultrasound-guided paravertebral blocks for anesthesia during breast surgery.
-
CLINICAL_TRIALS trial_result · 2016-06-24Clinical Trial Update: A Study Of PF-06263507 In Patients With Advanced Solid Tumors [Phase 1]
Phase 1 trial of PF-06263507 in advanced solid tumors has been terminated; results posted.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2016-03-03Clinical Trial Update: Understanding Shared Psychobiological Pathways [NA]
Clinical trial update for a completed study on shared psychobiological pathways related to breast neoplasms; results posted in 2016.
-
CLINICAL_TRIALS research · 2015-11-05Clinical Trial Update: TME Neoadjuvant Breast Registry
Clinical trial registry update for the TME Neoadjuvant Breast Registry sponsored by Targeted Medical Education; status is unknown.
-
CLINICAL_TRIALS trial_result · 2015-06-15Clinical Trial Update: Nuevo Amanecer: Promoting the Psychosocial Health of Latinas [NA]
Clinical trial update for a psychosocial health promotion study related to breast neoplasms; trial completed with results posted in 2015.
-
CLINICAL_TRIALS trial_result · 2015-05-20Clinical Trial Update: Comparison of Diagnostic Performance of Digital Breast Tomosynthesis and Ultrasound in Women With Dense Breasts
This clinical trial update compares the diagnostic performance of digital breast tomosynthesis and ultrasound in women with dense breasts. T…
-
CLINICAL_TRIALS research · 2015-04-14Clinical Trial Update: Photography or Video in Assessing Breast Reconstruction?
This completed trial from NHS Greater Glasgow and Clyde investigates whether photography or video can be used to assess outcomes after breas…
-
EMA withdrawal · 2015-03-12EMA Lapsed: Docetaxel Mylan (docetaxel) — Mylan S.A.S.
EMA status shows Docetaxel Mylan has lapsed; related indications include head and neck neoplasms, non-small cell lung carcinoma, adenocarcin…
-
CLINICAL_TRIALS trial_result · 2015-01-26Clinical Trial Update: Study to Assess The Efficacy and Safety of a PARP Inhibitor For The Treatment of BRCA-positive Advanced Breast Cancer [Phase 2]
Phase 2 trial evaluating a PARP inhibitor for BRCA-positive advanced breast cancer has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2014-09-10Clinical Trial Update: A Pilot Trial of Itraconazole Pharmacokinetics in Patients With Metastatic Breast Cancer [NA]
A completed pilot pharmacokinetics trial of itraconazole in patients with metastatic breast cancer; results posted in 2014.
-
CLINICAL_TRIALS withdrawal · 2014-08-25Clinical Trial Update: MBI and Breast Tomosynthesis Screening Accuracies in Patients With Dense Breast Tissue [NA]
A clinical trial evaluating molecular breast imaging (MBI) and breast tomosynthesis for screening in women with dense breast tissue has been…
-
CLINICAL_TRIALS research · 2014-02-03Clinical Trial Update: Detection and/or Evaluation of Dense Breast Abnormalities Using Tomosynthesis and Digital Mammography [EARLY_Phase 1]
An early-phase 1 clinical trial evaluating the detection and evaluation of dense breast abnormalities using tomosynthesis and digital mammog…
-
CLINICAL_TRIALS trial_result · 2013-09-09Clinical Trial Update: Ultrasound Elastography of Breast Lesions
This clinical trial evaluating ultrasound elastography for breast lesions has completed, with results posted in 2013.
-
EMA withdrawal · 2012-06-14EMA Withdrawn: Docefrez (docetaxel) — Sun Pharmaceutical Industries Europe B.V.
Withdrawn EMA entry for Docefrez (docetaxel) by Sun Pharmaceutical Industries Europe B.V.; listed indications include stomach neoplasms, ade…
-
CLINICAL_TRIALS trial_result · 2012-03-13Clinical Trial Update: Weekly vs. Every 2 Week vs. Every 3 Week Administration of ABI-007 (Abraxane)/Bevacizumab Combination in Metastatic Breast Cancer [Phase 2]
Phase 2 trial comparing different administration schedules of ABI-007 (Abraxane) with Bevacizumab in metastatic breast cancer; study termina…
-
CLINICAL_TRIALS trial_result · 2011-10-13Clinical Trial Update: Neo ALTTO (Neoadjuvant Lapatinib and/or Trastuzumab Treatment Optimisation) Study [Phase 3]
A phase 3 neoadjuvant study (Neo ALTTO) comparing lapatinib and/or trastuzumab for breast neoplasms has completed with results posted in 201…
-
EMA withdrawal · 2011-08-22EMA Application withdrawn: Ibandronic Acid Hexal (ibandronic acid) — Hexal AG
The EMA withdrew the application for Ibandronic Acid Hexal (ibandronic acid) from the market. Therapeutic areas listed include hypercalcemia…
-
CLINICAL_TRIALS trial_result · 2010-06-24Clinical Trial Update: Special Investigation For Patients With Renal And/Or Hepatic Disorders On Aromasin
This clinical trial update reports results from a special safety investigation of exemestane (Aromasin) in patients with renal and/or hepati…
-
CLINICAL_TRIALS trial_result · 2010-05-13Clinical Trial Update: Vaginal Testosterone Cream For Atrophic Vaginitis in Women Taking Aromatase Inhibitors for Breast Cancer. [Phase 1, Phase 2]
A Phase 1/2 trial of vaginal testosterone cream for atrophic vaginitis in women treated with aromatase inhibitors for breast cancer has been…
-
EMA withdrawal · 2010-03-26EMA Application withdrawn: Docetaxel Mylan (docetaxel) — Mylan S.A.S.
Withdrawal of the EMA application for Docetaxel Mylan (docetaxel) by Mylan S.A.S., affecting multiple solid tumor indications including non-…
-
EMA withdrawal · 2010-03-22EMA Withdrawn: Paxene (paclitaxel) — Norton Healthcare Ltd.
Paxene (paclitaxel) is withdrawn from consideration by Norton Healthcare Ltd., affecting indications including sarcoma (Kaposi), non-small c…
-
EMA withdrawal · 2009-03-19EMA Application withdrawn: Ixempra — Bristol-Myers Squibb Pharma EEIG
The EMA withdrew the marketing authorization application for Ixempra (paclitaxel) from Bristol-Myers Squibb Pharma EEIG in the breast cancer…